eGenesis reported that five patients have received genetically engineered porcine kidney transplants through an expanded access study, with three achieving sustained kidney function beyond eight months without dialysis. One patient exceeded nine months of dialysis independence, and two patients successfully transitioned to human donor kidneys, establishing clinical feasibility for xenotransplantation as a bridge or alternative to conventional transplantation.
Key Points
- Three patients sustained kidney function >8 months without dialysis
- One patient achieved 9+ months dialysis independence, a reported record
- Two patients transitioned from xenotransplant to human donor kidneys
Longevity Analysis
End-stage kidney disease reduces lifespan by years and impairs multiple regulatory systems through retained uremic toxins and fluid imbalance. Xenotransplantation with genetic modification addresses the scarcity of human donor organs and offers time-critical patients an alternative that restores filtration capacity, reducing circulatory and metabolic stress. The successful transition of two patients from engineered porcine to human-derived kidneys demonstrates the clinical viability of xenotransplants as functional bridges, not merely temporary solutions, which expands treatment options for patients who might otherwise remain dialysis-dependent or face mortality on transplant waiting lists.
Original published by LT Wire.